Advanced Technology Ventures

Venture Capital Exempt reporting adviser

Legal name: Atv Capital Management, Inc.

Boston, MA Website

AUM

$25.3M
Private fund assets

Private funds

1
Venture Capital 1

Private fund assets

$25.3M
Gross asset value

Employees

—

Last Form D raise

—

From SEC Form ADV filing (filed Mar 27, 2026). View on SEC

Investment focus

As listed in industry directories; may be out of date.

Geographies
USA

People(11)

Owners and executive officers named on the firm's SEC Form ADV.

D
Trustee of the Steven N. and Deborah D. Baloff Trust Dated May 13, 1998, The Steven N. and Deborah D. Baloff Trust Dated May 13, 1998
D
Trustee of the John R. and Diane I. Harrington Trust U/A Dated May 14, 1993, John R. Harrington and Diane I. Harrington, AS Trustees of the John R. and Diane I. Harrington Trust U/A Dated May 14, 1993
J
Director of Atv Capital Management
J
Trustee of the John R. and Diane I. Harrington Trust U/A Dated May 14, 1993, John R. Harrington and Diane I. Harrington, AS Trustees of the John R. and Diane I. Harrington Trust U/A Dated May 14, 1993
K
Trustee of the Henkens Family Survivors Trust U/A Dated June 1, 1999, Henkens Family Survivors Trust U/A Dated June 1, 1999
M
Trustee of the Carusi Family Trust Dated July 19, 2016, The Carusi Family Trust Dated July 19, 2016
M
President, Director of Atv Capital Management
R
Director of Atv Capital Management
S
Director of Atv Capital Management
W
Trustee of the Raffel Revocable Living Trust Dated November 7, 1995, The Raffel Revocable Living Trust Dated November 7, 1995
W
Vice President, Treasurer & Secretary, Director of Atv Capital Management

Funds(1)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Advanced Technology Ventures VIII, L.P.Venture Capital$25.3M———

Board seats(3)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

MediSix Therapeutics
BiotechnologyBoston, MADirector: Michael Carusi
$42.9M raised
Since Aug 2023
SEC Form D
Fuze
OtherBoston, MADirector: Robert Hower
$466.3M raised
Since Jan 2021
SEC Form D
Gemini Therapeutics
BiotechnologyCambridge, MADirector: Jean George
$2.0M raised
Since May 2016
SEC Form D

Shares boards with

Firms whose people sit on the same company boards.

Regulatory identifiers

CRD number
162341
SEC file number
802-75329

Sources